The Medical Growth House is part of Oslo MedTech and is also co-located with the newly established health incubator Aleap.
“Taking part in the vibrant environment in The Medical Growth House and the health incubator Aleap brings us right to the center of Norwegian MedTech and healthcare innovation. The location in Oslo Science Park, also housing StartupLab and a series of well established companies, start-ups and research institutes right at the doorstep of The University of Oslo, really provides a fascinating place for innovation”, comments CEO Svein-Erik Måsøy.
ODI Medical is developing technology for bedside measurement and quantification of circulatory failure based on assessment of microcirculation. Our concept, the Oxygen Delivery Index™, may be used for a wide range of clinical applications such as monitoring patients on mechanical heart and lung machines, evaluation of toxicity of chemotherapy, early detection of evolving sepsis; monitoring of chronic wounds, and mass screening of conditions such as Ebola, bird flu or endemic meningitis. ODI Medical is commercialising its concepts on the foundation of 30 years research from its founder, Professor Knut Kvernebo, from The Oslo University Hospital (OUS), Oslo, Norway.